Recent Quotes

My Watchlist

Indicators

Accolade Inc (NQ: ACCD )

3.500 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Oct 18, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	631
Open	3.500
Bid (Size)	3.470 (9)
Ask (Size)	3.530 (4)
Prev. Close	3.500
Today's Range	3.500 - 3.500
52wk Range	3.350 - 15.36
Shares Outstanding	76,232,192
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Forecasting The Future: 6 Analyst Projections For Accolade

October 09, 2024

Via Benzinga

Accolade's Q2 Boost: Revenue Rises, Losses Shrink, And Profitability Looms

October 08, 2024

Accolade stock up after beating Q2 2025 revenue and EPS estimates, expecting full year Adjusted EBITDA profitability and positive cash flow.

Via Benzinga

Performance

YTD	-71.10%	-71.10%
1 Month	-11.84%	-11.84%
3 Month	-6.42%	-6.42%
6 Month	-62.00%	-62.00%
1 Year	-47.92%	-47.92%

More News

Accolade Announces Results for Fiscal Second Quarter 2025

October 08, 2024

From Accolade, Inc.

Via GlobeNewswire

Dow Dips Around 400 Points As Treasury Yields Top 4%: Investor Optimism Declines, But Fear Index Remains In 'Greed' Zone

October 08, 2024

Via Benzinga

PepsiCo, MEDIROM Healthcare Technologies And 3 Stocks To Watch Heading Into Tuesday

October 08, 2024

Via Benzinga

Uncovering Potential: Accolade's Earnings Preview

October 07, 2024

Via Benzinga

Top Wall Street Forecasters Revamp Accolade Price Expectations Ahead Of Q2 Earnings

October 04, 2024

Via Benzinga

Accolade Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

February 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session

October 04, 2024

Via Benzinga

Accolade, Inc. (ACCD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

July 15, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Accolade, Inc. (ACCD) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

July 09, 2024

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Apple To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday

June 28, 2024

Via Benzinga

Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session

June 28, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

June 28, 2024

Via InvestorPlace

ACCD Investors Have the Opportunity to Join Accolade, Inc. Securities Fraud Investigation with The Schall Law Firm

June 27, 2024

From The Schall Law Firm

Via Business Wire

ACCD Stock Earnings: Accolade Beats EPS, Beats Revenue for Q1 2025

June 27, 2024

Via InvestorPlace

Accolade Stock Tumbles On Q1 Earnings, Weak Guidance: What You Need To Know

June 27, 2024

Via Benzinga

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

May 10, 2024

Via The Motley Fool

12 Health Care Stocks Moving In Friday's After-Market Session

April 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session

April 26, 2024

Via Benzinga

Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

April 26, 2024

Via Benzinga

ACCD Stock Earnings: Accolade Misses EPS, Beats Revenue for Q4 2024

April 25, 2024

Via InvestorPlace

Accolade Announces Results for Fiscal Fourth Quarter and Full Year 2024

April 25, 2024

From Accolade, Inc.

Via GlobeNewswire

Alphabet To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Monday

April 22, 2024

Via Benzinga

Alabama’s Fertility Ruling Raises Challenges for Stocks of Fertility Benefits Providers

February 23, 2024

Via InvestorPlace

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.